SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects

Dredge, K; Marriott, JB; Macdonald, CD; Man, HW; Chen, R; Muller, GW; Stirling, D; Dalgleish, AG (2002) Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. BRITISH JOURNAL OF CANCER, 87 (10). 1166 - 1172 (7). ISSN 0007-0920 https://doi.org/10.1038/sj.bjc.6600607
SGUL Authors: Dalgleish, Angus George

[img]
Preview
["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (293kB) | Preview

Item Type: Article
Additional Information: PubMed ID: 12402158
Keywords: 3',5'-Cyclic-AMP Phosphodiesterases, Angiogenesis Inhibitors, Animals, Cell Division, Cell Movement, Cyclic Nucleotide Phosphodiesterases, Type 4, Endothelium, Vascular, Female, Humans, Immunosuppressive Agents, Male, Mice, Rats, Thalidomide, Tumor Necrosis Factor-alpha, Science & Technology, Life Sciences & Biomedicine, Oncology, thalidomide analogues, anti-angiogenic, immunomodulatory, IMiDs, SelCIDs, ENDOTHELIAL-CELL PROLIFERATION, MULTIPLE-MYELOMA, U937 CELLS, TNF-ALPHA, IN-VITRO, CANCER, SURAMIN, GROWTH, ACTIVATION, INHIBITION, thalidomide analogues, anti-angiogenic, immunomodulatory, IMiDs, SelCIDs
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: BRITISH JOURNAL OF CANCER
ISSN: 0007-0920
Related URLs:
Dates:
DateEvent
4 November 2002Published
Web of Science ID: WOS:000179326600017
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: http://openaccess.sgul.ac.uk/id/eprint/718
Publisher's version: https://doi.org/10.1038/sj.bjc.6600607

Actions (login required)

Edit Item Edit Item